Search Results 1 – 20 of 36
Pre-exposure Prophylaxis (PrEP) to Reduce the Risk of Acquiring HIV During Periconception, Antepartum, and Postpartum Periods
HHS Adults and Adolescents Antiretroviral Guidelines Panel Recommendation for the Long-Acting Injectable Antiretroviral Regimen of Cabotegravir and Rilpivirine
Preconception Counseling and Care for Women of Childbearing Age Living with HIV
Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Limitations to Treatment Safety and Efficacy
Considerations for Antiretroviral Use in Patients with Coinfections
Appendix A: Key to Acronyms
Antepartum Care
Appendix B: Drug Characteristics Tables
Laboratory Testing
Management of the Treatment-Experienced Patient
Management of Infants Born to Women with HIV Infection
Drug-Drug Interactions
Introduction
Maternal HIV Testing and Identification of Perinatal HIV Exposure
Special Patient Populations
Financial Disclosure
Appendix C: Antiretroviral Counseling Guide for Health Care Providers
Intrapartum Care for Women with HIV
Conclusion